Montrium works with BioPharmaceutical organizations of all sizes within Canada, United States and Europe. Montrium’s clients include:
Established in 1888, Abbott Laboratories, Inc. is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritional, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries. Serving the Canadian population since 1931, Abbott Canada employs 2,000 individuals.
To learn more visit Abbott
Please visit Aegera Therapeutics’ website for current Company information.
Allergan, Inc. is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential — to see more clearly, move more freely, express themselves more fully.
To learn more visit www.allergen.com
Axcan Pharma Inc. is a privately-held leading specialty pharmaceutical company focused on gastroenterology. We market a wide range of products to treat gastrointestinal diseases and disorders, such as Inflammatory Bowel Disease, cholestatic liver diseases, Irritable Bowel Syndrome and pancreatic enzyme insufficiency.
To learn more visit www.axcan.com
Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 190 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health.
For more information, please visit www.Bioniche.com.
Helix BioPharma Corp. is a biopharmaceutical company developing novel products for the treatment of cancer and precancerous conditions. Helix is listed on the Toronto Stock Exchange under the trading symbol ‘’HBP’’. Helix’s vision is to develop a portfolio of effective new anti-cancer therapeutics based on its innovative technologies and bring these products to patients worldwide.
To learn more visit www.helixbiopharma.com
Ironwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. They are passionate about delivering new medicines to patients that make a significant difference in their lives.
To learn more visit www.ironwoodpharma.com
LifeCycle Pharma A/S is an emerging specialty pharmaceutical company. Clinical development is the core of LCP’s effort to develop a product portfolio which includes products for immunosuppression, specifically organ transplantation, and products to combat certain cardiovascular diseases.
To learn more visit www.lcpharma.com
H.Lundbeck A/S is an international pharmaceutical company conducting research into, developing, manufacturing, marketing, selling and distributing pharmaceuticals for the treatment of neurological disorders, including depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease and insomnia.
To learn more visit www.lundbeck.com
MethylGene Inc. (TSX:MYG) is a publicly-traded, clinical stage, biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for cancer.
To learn more visit www.methylgene.com
Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of neurological and psychiatric diseases. Merz is leading in the field of Alzheimer's research and developed the world's first drug for the treatment of moderate to severe stages of Alzheimer's disease. In the neurological sector, Merz also offers drugs for the treatment of Parkinson's, depression and dystonia. Another area of competence is dermatology. Merz is one of the leading suppliers in aesthetic dermatology and offers products that beautify their users. In clinical dermatology, medications from Merz focus on the treatment of scars, acne, hair loss and fungal diseases. In the field of metabolic disorders, Merz offers therapies for liver disease and lipid metabolism disorders.
To learn more visit www.merz.com